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Abstract: Background: Total knee arthroplasty can be considered as a reliable surgical procedure with a good long-term 
clinical result. However, implant failure due to particle induced aseptic loosening as well as the aspect of hypersensitivity 
to metal ions still remains an emerging issue. 
Methods: The purpose of this prospective international multi-centre study was to evaluate the clinical and radiological 
outcomes and the reliability of the unconstrained Multigen Plus Total Knee System with a new BIOLOX
 delta ceramic 
femoral component. Cemented total knee arthroplasty was performed on 108 patients (110 knees) at seven hospitals in 
three countries. Clinical and radiological evaluations were performed preoperatively, and after 3, 12 and 24 months 
postoperatively using the HSS-, WOMAC-, SF-36-score and standardised X-rays. 
Results: The mean preoperative HSS-Score amounted to 55.5 ± 11.5 points and improved significantly in all postoperative 
evaluations (85.7 ± 11.7 points at 24 months). Furthermore, improvements in WOMAC- and SF-36-score were evaluated 
as significant at all points of evaluation. Radiolucent lines around the femoral ceramic component at 24 months were 
found in four cases. Progression of radiolucent lines was not seen and no implant loosening was observed. During the 24 
month follow-up eight patients underwent subsequent surgery due to reasons unrelated to the implant material. 
Conclusions: The observed clinical and radiological results are encouraging for a long-term survival of the ceramic 
femoral component. Therefore, ceramic implants could be a promising solution not only for patients with allergies against 
metallic implant materials, but also for the osteoarthritic knee joint. Long-term follow-up is necessary to draw conclusions 
regarding the superiority of the ceramic knee implants concerning in vivo wear and long-term survivorship. 
Keywords: Ceramics, functional outcome, radiological outcome, total knee arthroplasty. 
INTRODUCTION 
  Total knee arthroplasty (TKA) is one of the most 
successful principles in orthopaedic surgery [1].  
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Nevertheless, particle-induced aseptic loosening is, along 
with malpositioning, a major reason for implant failure 
especially in younger active patients. The ‘Swedish Register’ 
shows a cumulative revision rate of 6.5% for patients under 
65 years old and 2.5% for patients over 65 years after 8.5 
years of follow-up [2]. Thus the demand for a maximum 
clinical outcome led to improvements in implant fixation, 
coupling wear and specific designs in order to obtain longer 
survival rates and an increased range of motion [3]. Ceramic Femoral Components in TKA  The Open Orthopaedics Journal, 2012, Volume 6    173 
Furthermore, allergies to implant materials, e.g. chromium, 
cobalt and nickel, have been found to cause implant failure. 
Skin reactions to metal ions are described as being up to 
20% [4], but there are no valid clinical data on the incidence 
of implant allergies so far. Ceramics therefore may be a 
solution for patients with allergies to implant materials and 
may have an improved resistance to wear, followed by 
reduced aseptic loosening rates [5]. Since the biologic effect 
of wear particles depends on the material and volume of 
wear particles, materials with less wear are of scientific 
interest [3]. Meanwhile, the worldwide use of ceramics in 
total hip arthroplasty (THA) is justified because of its high 
chemical and mechanical stability, its extreme resistance to 
wear and corrosion, due to the lack of an electrochemical 
reaction and excellent tribology [6]. Nevertheless, there is 
still a high brittleness in alumina ceramics, i.e. there is less 
plastic deformation in contrast to ductile metallic or polymer 
materials, and low tensile strength. Therefore, stress 
concentration, e.g. on sharp edges, must be avoided during 
implantation and the implant design must consider weak 
spots [7, 8]. 
  At the knee, the first biocompatible ceramic product was 
implanted as a unicondylar tibial surface replacement by 
Langer in 1972 and resulted in limited wear between the 
ceramic and cartilage [9]. The first alumina ceramic (Al2O3) 
total knee prosthesis was realised by the Kyocera Corp. 
(Kyoto, Japan) and implanted by Oonishi in the early 1980s 
[10]. 
  In THA, articulating components are used with optimum 
contact contributions, resulting in limited local stresses, even 
if joint loads are high. In contrast, TKA requires components 
(especially the femoral component) with shapes and contact 
conditions that necessarily result in high stresses near the 
corners of femoral resections (tension stress) and at the 
points of contact with the polyethylene (shear stress). In a 
finite-element-analysis (FEA) 3-D models of the ceramic 
femoral component surrounding the femoral bone stock and 
the connecting bone cement revealed critical stresses, when 
considering the femoral bone stock morphology [11]. 
Stresses close to the fatigue limit of 1150 MPa provided by 
BIOLOX
 delta ceramic could be found in the intersections 
of resection surfaces and at the sharp change of sections at 
the distal part of component [12]. 
  By using the BIOLOX
 delta ceramic (CeramTec, 
Plochingen, Germany), it was possible to develop a femoral 
component with a tensile strength that meets the demands for 
application in TKA. BIOLOX
 delta ceramic is a composite 
matrix material containing 82% vol. alumina (Al2O3) and 
17% vol. zirconia (ZrO2) providing good mechanical 
characteristics in terms of strength and resistance [13]. 
Furthermore, the low friction coefficient of the novel 
BIOLOX
 delta ceramic causes a change in load. 
  The purpose of this international prospective multi-centre 
study was to evaluate the clinical and radiological two year 
follow-up of the total knee prosthesis with a BIOLOX
 delta 
ceramic femoral component. 
MATERIALS AND METHODS 
  Lima Corporate (Villanova di San Daniele, Udine, Italy) 
in collaboration with CeramTec provided BIOLOX
  delta 
ceramic femoral components with a design identical to those 
made of a cobalt-chromium alloy for the Multigen Plus Total 
Knee Replacement System, which is available and in use 
since 1997 (Fig. 1). Therefore, the surgeon was able to use 
the well-known instruments as well as retain the 
intraoperative possibility of choosing the most appropriate 
implant material for the patient. The Multigen Plus Ceramic 
Knee is a non-constrained surface replacement consisting of 
a symmetric, cruciate-retaining (CR), cemented BIOLOX
 
delta ceramic femoral and metal (TiAl6V4) tibial 
components. The fixed-bearing standard ultra-high 
molecular weight polyethylene liner (UHMWPE) is 
available in different thicknesses (10 mm, 12 mm, 14 mm, 
17 mm and 20 mm). 
 




Enrolment of the Study Group 
  A total of 108 patients were enrolled in the study at seven 
centres (three in Germany, three in Italy and one in Spain). 
Two patients underwent bilateral TKAs in a period greater 
than one year. Two patients included in the study underwent 
bilateral TKAs outside of the enrolment time frame. The 
study group included 81 (73.6%) TKAs in female and 29 
(26.4%) TKAs in male patients. Surgery was performed on 
48 (43.6%) left and 62 (56.4%) right knees. The average 
height and weight of the patients were 165.9 ± 7.7 (150–185) 
cm and 79.0 ± 11.7 (52–103) kg respectively. BMI and age 
was 28.7 ± 3.5 (19.1–33.6) and 67.7 ± 6.0 (48–75) 
respectively. 
  The study was performed as a prospective non-
comparative study for the clinical and radiological evaluation 
of the BIOLOX
® delta ceramic femoral component and was 
classified as evidence based medicine (EBM) level 4. 
Inclusion criteria were the indication for primary TKA due 
to primary osteoarthritis or rheumatoid arthritis. Severe 174    The Open Orthopaedics Journal, 2012, Volume 6  Bergschmidt et al. 
instability or deformity without the possibility for a stable 
surface replacement was determined as contraindication. 
Further contraindications for study enrolment were an age of 
more than 75 years old, BMI > 33 kg/m
2, any kind of 
infection, severe osteoporosis, patient history of tumours, as 
well as post-traumatic osteoarthritis and contra lateral TKA 
or joint replacement of the operated limb within one year. 
Haemophilic patients, patients with neurosensory or 
neuromotor deficits, which affects product evaluation or 
rehabilitation of the patient and patients with chronic and 
progressive severe diseases or known incompatibility or 
allergy to the used products were additionally excluded from 
the study. This study was ethics committee approved and all 
patients gave informed written consent. 
Intra- and Perioperative Management 
  All patients underwent a standard surgical procedure by 
one or a maximum of two experienced orthopaedic surgeons 
at each centre, using the Payr approach. The learning curve 
was reduced by sufficient experience with the identical 
metallic femoral component of the Multigen Plus Knee 
System. Implant size and the angle of the femur were 
determined preoperatively on standard anterior-posterior, 
lateral, whole leg (anterior-posterior) and Merchant view X-
rays. Cementation was achieved with high-viscosity bone 
cement. Before reconstruction of the quadriceps pulley, a 
shaping and denervation of the patella and an optimal soft 
tissue balancing was obligatory in all cases. Prevention of 
deep vein thrombosis and pulmonary embolism was 
accomplished by a daily subcutaneous application of a low 
molecular weight heparin and anti-thrombotic stockings 
during the hospital and rehabilitation stay. All patients 
underwent full weight-bearing with two crutches beginning 
on the second postoperative day after drain removal. 
Clinical and Radiological Evaluation of the Patients 
  Clinical evaluations were performed preoperatively as 
well as at 3.1 ± 0.5, 12.1 ± 1.1 and 25.3 ± 3.6 months 
postoperatively using the HSS-, WOMAC- and SF-36 score 
[14]. The HHS score has a maximum of 100 points and 
considers subjective functional (62%) as well as objective 
examination criteria (38%). The domains include pain (30 
points), function (22 points), range of motion (18 points), 
muscular strength (10 points), deformity (10 points) and 
instability (10 points). 
  Radiological evaluation were performed by standard 
anterior-posterior and lateral X-rays taken on day 5 
postoperatively, providing a baseline and at each point of the 
evaluation. Radiolucent lines and osteolysis of the femoral 
and tibial bone stock and implant positioning were evaluated 
by three independent observers. Implant position was 
measured by the medial distal femur angle (MDFA), medial 
proximal tibia angle (MPTA), posterior distal femur angle 
(PDFA) and posterior proximal tibia angle (PPTA). 
Statistical Analysis 
  All data were stored and analysed using the SPSS 
statistical package 15.0 (SPSS Inc. Chicago, Illinois, USA). 
Descriptive statistics were computed for continuous and 
categorical variables. The statistical evaluation included 
means and standard deviations (SD) of continuous variables, 
frequencies and relative frequencies of categorical factors. 
For continuous variables the interval mean ± SD are 
presented. Comparisons were performed by the Friedman-
test (FR) and the Wilcoxon test (WI), respectively between 
the time points of clinical and radiological evaluations. Test 
selection was based on evaluating the variables for normal 
distribution employing the Kolmogorov-Smirnov test. All p 
values resulted from two-sided statistical tests and values of 
p < 0.05  were considered to be statistically significant. If 
necessary, adjustments of the alpha level were carried out by 
Bonferroni correction. That means that we have lowered the 
level of significance to 0.05/6 = 0.008 for paired 
comparisons between the four time points of evaluation. 
RESULTS 
  Overall, 110 total knee arthroplasties were enrolled in the 
study, but the number of evaluated knees was reduced to 104 
at 3 months, 102 at 12 months and 96 at 24 months. At 3 
months, six patients could not be evaluated as one patient 
had died due to myocardial infarction and three patients 
withdrew consent for personal reasons. In one case, the 
patient was lost to follow-up for unknown reasons. An 
intensive effort to find out the reason did not yield any 
results. One patient was not evaluated at 3 months for 
personal reasons, but was followed up at 12 and 24 months. 
Three patients dropped out at the 12 months evaluation, one 
patient due to a gastric cancer that required a prolonged 
hospital stay, one patient with a bilateral implantation 
underwent explantation of one TKA due to early infection 
and one patient was not evaluated at 12 months but 
underwent the 24 month follow-up. At 24 months seven 
patients could not be evaluated as one patient had died due to 
natural reasons, four patients withdrew consent for personal 
reasons and in two patients the implant was explanted due to 
infection. One of these cases was caused by postoperative 
opening of the knee joint because of direct trauma one week 
after hospital discharge and revision surgery with change of 
insert could not prevent prolonged infection. Five patients 
underwent reoperation due to reasons unrelated to the 
implant materials without revision of the ceramic 
component. One patient underwent osteosynthesis due to a 
periprosthetic fracture after trauma, in two patients a retro-
patellar replacement was inserted at one year 
postoperatively, in one patient there was a change of insert 
due to traumatic instability and in one patient an arthrolysis 
was performed in order to improve poor range of motion. 
 HSS-, WOMAC- and SF-36 scores improved 
significantly (WI test p < 0.001) from the preoperative to the 
postoperative evaluations at 3, 12 and 24 months (Table 1). 
Improvements in all scores were seen especially up to 12 
months, whereas differences in all scores between 12 and 24 
months were small. Significant improvements were seen in 
the domains of pain, function, muscular strength, deformity 
and instability. Range of motion and correspondent domain 
motion was evaluated as non-significantly decreased at 3 
months in comparison to the preoperative assessment (WI 
test p = 0.013). The 12 and 24 months evaluation revealed 
significant improvement of domain motion and range of 
motion in comparison to the 3 months (WI test p < 0.001) 
and non-significant improvement in comparison to the 
preoperative assessment (WI test p  0.022). Nevertheless, 
the early postoperative period up to 3 months showed the 
highest decrease in pain and functional derogation. Ceramic Femoral Components in TKA  The Open Orthopaedics Journal, 2012, Volume 6    175 
Table 1.   Mean Pre- and Postoperative HSS-, WOMAC- and SF-36 Score Values Including Domains of HSS Score and Range of 
Motion 
 
  Preoperative (I)  3 Months (II)  12 Months (III)  24 Months (IV)  FR-Test  WI-Test 
HSS score (100)  55.5 SD 11.5  77.2 SD 10.3  85.6 SD 8.9  85.7 SD 11.7  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p<0.001 
III vs IV p=0.387 
Pain (30)  10.1 SD 6.6  22.9 SD 5.8  26.3 SD 5.1  26.6 SD 5.9  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p<0.001 
III vs IV p=0.355 
Function (22)  12.6 SD 4.3  16.9 SD 3.5  18.6 SD 4.0  18.9 SD 3.3  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p<0.001 
III vs IV p=0.761 
Motion (18)  13.6 SD 1.9  12.9 SD 1.7  14.0 SD 1.9  13.8 SD 2.7  p<0.001  I vs II p=0.013 
I vs III p=0.087 
I vs IV p=0.066 
II vs III p<0.001 
II vs IV p<0.001 
III vs IV p=0.971 
Muscular strength (10)  7.6 SD 2.6  8.7 SD 2.1  9.5 SD 1.3  9.6 SD 1.0  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p=0.002 
III vs IV p=0.423 
Deformity (10)  7.1 SD 2.8  9.0 SD 2.0  9.8 SD 0.5  9.8 SD 0.8  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p=0.002 
III vs IV p=0.967 
Instability (10)  8.1 SD 1.5  9.7 SD 0.7  9.6 SD 0.9  9.6 SD 0.9  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p=0.050 
III vs IV p=0.740 
WOMAC score (100)  48.1 SD 16.6  63.9 SD 18.5  74.1 SD 17.4  71.5 SD20.0  p<0.001  I vs II p<0.001 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p<0.001 
II vs IV p<0.001 
III vs IV p=0.961 
SF-36 score (100)  49.1 SD 17.6  56.2 SD 21.3  63.9 SD 19.2  62.3 SD 22.6  p=0.001  I vs II p=0.004 
I vs III p<0.001 
I vs IV p<0.001 
II vs III p=0.007 
II vs IV p=0.010 
III vs IV p=0.786 
ROM  108.8° SD 15.7°  103.3° SD 13.3°  112.3° SD 15.1°  112.6° SD 15.0°  p<0.001  I vs II p=0.013 
I vs III p=0.087 
I vs IV p=0.022 
II vs III p<0.001 
II vs IV p<0.001 
III vs IV p=0.792 
Standard deviation (SD) and p-values for the Friedman (FR) and Wilcoxon (WI) test are presented. Significant differences are marked with bold letters. 176    The Open Orthopaedics Journal, 2012, Volume 6  Bergschmidt et al. 
Radiological Results 
  The positioning of the implant in the postoperative 
radiographs is demonstrated in Table 2. An intraoperative 
intramedullary valgus alignment between 5° and 9° 
depending on the preoperative valgus of the femur was used 
and the pre-defined implant slope was 7°. Implant 
positioning was considered as optimal (aberrance < 3°), as 
fair (> 3° and < 5°) and as poor (> 5°). Changes in implant 
position or migration during the 24 month follow-up were 
not observed in any cases (Fig. 2). 
Table 2.  Implant Position Measurement Demonstrated by the 
Medial Distal Femur Angle (MDFA), Medial 
Proximal Tibia Angle (MPTA), Posterior Distal 
Femur Angle (PDFA) and Posterior Proximal Tibia 
Angle (PPTA). 
 
Implant Position (Number of Patients in %) 
  Optimal (<3°)   Fair (3°–5°)   Poor (>5°)  
MDFA   55 (50.0%)   32 (29.1%)   23 (20.9%)  
MPTA   46 (41.8%)   47 (42.7%)   17 (15.5%)  
PDFA   73 (66.4%)   29 (26.4%)   8 (7.3%)  
PPTA   31 (28.2%)   39 (35.5%)   40 (36.4%)  
 
  Radiolucent lines around the femoral ceramic component 
at 24 months were found in 3 cases in one zone and in 1 case 
in two zones. All radiolucent lines measured up to a 
maximum of 1 mm and were located between the bone and 
cement (Fig. 3). Radiolucent lines around the tibial 
component were found in 17 cases after 24 months follow 
up. Zone 1 (n=8) and zone 4 (n=9) showed the majority of 
radiolucent lines, up to 2 mm, which were located between 
the bone and cement. Progression of radiolucent lines was 
not seen around the femoral and the tibial component in any 
case. Within the clinical evaluation, implant loosening 
cannot be assumed in any case. 
DISCUSSION 
  Since the number of primary TKAs, especially in 
younger patients, is increasing, the demand for the best 
available outcome, including higher mechanical loading and 
optimal kinematics (maximum range of motion) has become 
more important for excellent long-term function and 
stability. Wear is one major reason for implant failure in 
TKA [3]. The biologic effect of wear particles depends on 
the material and volume of wear particles. Furthermore, 
modern TKA components are made of titanium or cobalt-
chromium alloys. Cobalt-chromium and nickel have the 
greatest potential to cause allergic reactions [4]. Bioinert 
ceramic implants are an option for metal sensitive patients 
and can reduce the release of wear particles. Therefore, 
ceramic implant designs for TKA were developed [3, 5, 13, 
15]. 
  In this prospective international multi-centre study, we 
examined a total knee replacement system with the 
BIOLOX
 delta ceramic femoral component concerning 
early radiological and functional outcome. The study was 
performed as a prospective non-comparative study for 
evaluation of the ceramic femoral component. The first 
limitation of the study is that selected patients were not 
consecutive or randomised and the degree of the deformity 
was, in general, moderate. The reasons for these limitations 
were correlated with the nature of the study and with proving 
the clinical reliability of the newly developed ceramic 
femoral component. 
  The radiological evaluation revealed radiolucent lines 
around the femoral ceramic component in four cases. In 
contrast, we observed radiolucent lines on the tibial side in 
up to 16%. This may be due to a stress-shielding 
phenomenon and is described up to 17%. Progression can 
usually not be expected if a malalignment is non-existant 
[16, 17]. However, subsequent follow-up investigations have 
to be performed to clarify if the progression of radiolucent 
lines influence clinical results and implant survival rates. 
  The clinical evaluation showed significant improvements 
in all scores from the preoperative to the postoperative 
evaluations. The early postoperative period (up to 3 months) 
revealed the highest decrease in physical and psychological 
functional derogation, with the exception of range of motion 
[1]. Aarons et al. [18]  evaluated differences of the early 
functional outcome after TKA and THA. After THA, patients 
showed significant improvement in physical function and 
quality of life after 7 weeks, but in patients with TKA, these 
 
Fig. (2). X-rays of a 75-year-old female preoperative, 5 days and 24 months after the implantation of a Delta Ceramic Multigen Plus Knee 
with BIOLOX
 ceramic femoral component. Ceramic Femoral Components in TKA  The Open Orthopaedics Journal, 2012, Volume 6    177 
early effects could not be evaluated. Within the first 7 
postoperative days, psychological aspects improved similarly in 
the TKA and THA groups, due to the relief of preoperative 
stress and depression. With regard to these findings, range of 
motion as a functional aspect improved most between 3 and 12 
months. Overall, improvement can be expected to a minimum 
of 2 years postoperatively and were seen in the study [19]. 
 
Fig. (3). Lateral X-ray 12 months after implantation of a Delta 
Ceramic Multigen Plus Knee with BIOLOX
  ceramic femoral 
component. A radiolucent line up to 1 mm is seen in Zone 1. 
  We observed a higher HSS score of 85.6 points at 3 
months postoperatively in comparison to 75.6 points using a 
different non-constrained surface replacement knee system 
[1]. The clinical outcome of the Multigen Plus Knee with a 
BIOLOX
 delta ceramic femoral component demonstrates 
results comparable to other studies, which reported a mean 
postoperative (1 year) HSS score between 85.0 to 93.0 points 
[20, 21]. Evaluations of other ceramic TKAs showed a HSS 
score of 86 points after a follow up between 2 and 10 years 
[22-24]. Bin et al. [20] evaluated the range of motion of a 
knee system in both standard and high flexion designs. 
Achieving an excellent HSS scores in both study groups 
(HSS score 92.0–93.0), significant differences in range of 
motion were found (129.8° ± 5.2° versus 124.3° ± 9.2°). 
TKAs using ceramic components evaluated range of motions 
between 113°–124° [23, 24]. The Multigen Plus Knee, as a 
standard design prosthesis, shows a slightly reduced range of 
motion at 112.3° ± 15.1° (range 70°–150°). However, the 
comparability of different clinical studies is compromised by 
some influencing factors, such as implant design, 
preoperative function and the demographics of the study 
patients. 
 Oonishi  et al. [10] reported the results of 108 patients 
mainly treated with surgery with cementless total alumina 
prosthesis. There were 9 cases of aseptic loosening with 
implant dislocation at a follow-up between 5 and 8 years. 
Therefore, fixation of ceramics without cement is not 
recommended and the Multigen Plus Knee in our study was 
only implanted with PMMA cement with a cement layer of 
approximately 2 mm. Leyen et al. [25] recommended that 
ceramic knee endoprostheses should be fixed with bone 
cement. Bone cement can act as a force transmitter between 
bone and ceramics with two different Young’s modulus. 
Experimental testing showed that thinner cement layers lead 
to an increase in tensile bond strength [25].  A recently 
published  in vitro study rejected the hypothesis that 
cemented ceramic TKA femoral components are more prone 
to mechanical loosening [26]. Furthermore, future efforts 
have to be made to modify ceramic surfaces in order to 
realise cementless fixation by bony in-growth, in the event of 
allergies to bone cement components. 
  Material fractures are considered a problem of ceramics 
in joint arthroplasty. Long-term results (follow-up ranging 
from 5 to 10 years) of 105 cemented alumina ceramic knee 
prostheses (Kyocera Corp., Kyoto, Japan) showed a tibial 
plate fracture in one case, but the fracture of metal implants 
have also been reported [22, 24, 27]. BIOLOX
® delta 
ceramic is a composite matrix material containing 
aluminium oxide (Al2O3) and zirconium oxide (ZrO2), 
which has improved the mechanical characteristics in terms 
of strength and resistance. In the case of ceramics, once the 
elastic limit has been overcome due to a defect, the crack 
will propagate and a complete fracture will occur. Zirconium 
oxide particles, which are finely distributed in the stable 
alumina matrix, will change phase from tetragonal to 
monoclinic once there is a crack. This phase change 
increases the particle volume up to approximately 5%, which 
helps reduce energy consumption and can stop crack 
propagation by closing the crack space [15]. 
  We observed four fractures of the BIOLOX
 Delta 
ceramic femoral condyle during the implantation procedure 
at the beginning of the study, with no consequences for the 
patients. However, no fractures of the implanted components 
were observed during the 24 month follow-up. Failure 
analysis showed that the fracture lines were located in the 
corners of the femoral resection. Fractures may happen 
during the surgery procedure due to an inadequate anterior 
and posterior bone resection resulting in high tension stress 
during the impaction of the femoral condyle with a hard 
instrument (hammer). Finite-element analysis confirmed this 
fact [11]. Therefore, a precise intraoperative preparation of 
the bone stock and the use of a newly developed additional 
resection template for an extended anterior and posterior 
resection are required to avoid stress concentration by 
reducing wedge loading during impaction. The additional 
resection leads to an adequate thickness of the cement layer 
[25]. 
CONCLUSIONS 
  The good short-term results of the present study indicate 
a successful implementation of the Multigen Plus Knee with 
BIOLOX
  delta ceramic femoral component in clinical 
application. Ceramic implants are a promising solution for 
patients with allergies against metallic implant materials [28, 
29]. However, careful intraoperative handling has to be 
considered using ceramic femoral components. A long-term 
prospective comparative study with the ceramic and metallic 
Multigen Plus Knee is in progress in order to compare the 
clinical results and implant survival rates. 178    The Open Orthopaedics Journal, 2012, Volume 6  Bergschmidt et al. 
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